How Testosterone Enanthate Affects SHBG

Exogenous testosterone and all anabolic-androgenic steroids suppress hepatic SHBG production. SHBG drops within 1-2 weeks of starting TRT, increasing the free testosterone fraction. The degree of suppression is dose-dependent and more aggressive with oral 17-alpha-alkylated steroids.

The Mechanism

Exogenous androgens suppress sex hormone-binding globulin (SHBG) through direct action on hepatic androgen receptors.

Primary mechanism:

  • SHBG is produced by hepatocytes (liver cells). Androgen receptor activation in the liver directly downregulates the transcription of the SHBG gene, reducing protein synthesis and secretion into the bloodstream.
  • The suppression begins within days of starting testosterone and reaches a new equilibrium within 1-2 weeks at stable doses.

Dose-dependence:

  • The relationship between androgen dose and SHBG suppression is dose-dependent but not linear. Even TRT doses (100-200 mg/week) produce meaningful suppression. Supraphysiological doses drive SHBG progressively lower, with some users reaching near-zero levels.

Route of administration matters:

  • Oral 17-alpha-alkylated (17-aa) steroids (Dianabol, Anavar, Winstrol) suppress SHBG far more aggressively than injectable testosterone because they pass through the liver in high concentrations during first-pass metabolism, delivering an intense androgenic stimulus directly to hepatocytes.
  • Injectable testosterone produces more moderate SHBG suppression because the liver sees lower, more diffuse androgen concentrations after systemic distribution.

Effect on free testosterone:

  • SHBG binds testosterone with high affinity, rendering it biologically inactive. Lower SHBG means a greater proportion of total testosterone is unbound (free) and bioavailable.
  • Critically, total testosterone and free testosterone can move in opposite directions if SHBG changes significantly. A man with very low SHBG may have a lower total testosterone reading but very high free testosterone, and vice versa.

Expected Changes

TRT doses (100-200 mg/week):

  • SHBG typically decreases 30-50% from baseline within the first 4-8 weeks
  • A pre-TRT SHBG of 40 nmol/L may drop to 20-28 nmol/L
  • This substantially increases the free testosterone fraction
  • Most men on TRT stabilise with SHBG in the 15-30 nmol/L range

Supraphysiological doses (300-600+ mg/week):

  • SHBG suppression of 50-70% is common
  • Values below 15 nmol/L are frequently seen
  • Some users on very high doses or oral steroid stacks see SHBG drop below 5 nmol/L (near-zero)

Oral 17-aa steroids (Dianabol, Anavar, Winstrol):

  • Even modest oral steroid doses can suppress SHBG by 50-80% within days to 1-2 weeks
  • Winstrol (stanozolol) is particularly notable for aggressive SHBG suppression; it is sometimes used specifically to lower SHBG before a competition

Timeline: Suppression begins within 3-7 days of starting exogenous androgens and reaches a new stable level within 2-4 weeks. SHBG returns toward baseline within 4-8 weeks after discontinuation, though recovery timeline varies by compound half-life.

Monitoring Guidance

Baseline: Always measure SHBG before starting TRT or any AAS cycle. Baseline SHBG is essential context for interpreting total testosterone and calculating free testosterone. Men with very low baseline SHBG (below 20 nmol/L) may not need as much testosterone to achieve optimal free testosterone levels.

Frequency on TRT:

  • Check SHBG at 6-8 weeks (first follow-up) alongside total testosterone
  • Every 3-6 months once stable
  • Recheck whenever total testosterone appears inconsistent with clinical response, as SHBG changes frequently explain the discrepancy

Always pair SHBG with total testosterone: SHBG must be interpreted alongside total testosterone to calculate or estimate free testosterone. The Vermeulen equation or online free testosterone calculators provide a clinically useful estimate when direct free testosterone measurement is not available.

Thyroid and SHBG: Thyroid function directly influences SHBG. Hypothyroidism lowers SHBG; hyperthyroidism raises it. If SHBG changes unexpectedly, check TSH. This is a common and underappreciated interaction.

Other factors that affect SHBG:

  • Insulin resistance lowers SHBG (high insulin directly suppresses hepatic SHBG production)
  • Obesity lowers SHBG
  • Liver disease can raise or lower SHBG depending on the type and severity
  • Aging typically raises SHBG

Management Strategies

Low SHBG on TRT is expected and generally not concerning:

  • Suppressed SHBG is a direct pharmacological effect of androgen therapy. It should not be treated as pathology in isolation.
  • The clinical question is not "is SHBG suppressed?" but "what does this mean for my free testosterone level and clinical response?"

If SHBG is very low (below 10-15 nmol/L) with symptoms of androgen excess:

  • Consider that free testosterone may be higher than total testosterone suggests
  • Reduce testosterone dose before attributing symptoms to other causes
  • More frequent injections (daily or every other day) produce lower peaks and typically result in slightly higher SHBG than infrequent large-dose injections, as SHBG suppression is partly driven by peak androgen concentration

Injection frequency and SHBG:

  • Less frequent injections (weekly or biweekly) produce higher testosterone peaks, which drive greater SHBG suppression and create more androgenic "spikes"
  • More frequent, smaller injections (every 2-3 days, or daily subcutaneous) produce lower peaks and more stable hormone levels, often resulting in slightly higher SHBG and more stable free testosterone
  • This is clinically relevant for men who feel well at weekly injections versus those who feel their dose "wears off" before the next injection

If SHBG is very low with rapid testosterone clearance:

  • Low SHBG means testosterone is cleared from the bloodstream faster (free testosterone is more rapidly taken up by tissues and metabolised)
  • Men with very low SHBG on weekly injections may feel their dose wearing off by days 5-6
  • Switching to more frequent smaller injections resolves this for most users

Thyroid optimisation:

  • If SHBG is persistently low despite modest testosterone doses, check TSH and free T4. Subclinical hypothyroidism can suppress SHBG independently of androgen use, and treating hypothyroidism normalises SHBG.

Clinical Significance

SHBG suppression on TRT is expected, dose-dependent, and usually clinically benign. Its primary importance is interpretive: SHBG must be measured alongside total testosterone to understand how much bioavailable (free) testosterone is actually circulating. Men with very low SHBG may have excellent free testosterone despite modest total testosterone readings, and vice versa. Secondary clinical significance relates to injection frequency: very low SHBG accelerates testosterone clearance, which can cause end-of-dose symptoms and may require protocol adjustment. SHBG is also a useful indirect marker of metabolic health and insulin sensitivity.

Frequently Asked Questions

See how this interaction affects your blood work

Upload your blood tests and log your compounds to see personalised interaction data overlaid on your marker trends.

Quick Facts

Effect Direction

Suppresses

Severity

moderate

Dose-Dependent

Reversible